Clinical significance of variants of unknown significances in genes.
作者信息
Choi Min Chul
机构信息
Hereditary Gynecologic Cancer Clinic, Precision Medicine Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
出版信息
J Gynecol Oncol. 2019 Jul;30(4):e80. doi: 10.3802/jgo.2019.30.e80. Epub 2019 May 9.
Abstract
摘要
相似文献
1
Clinical significance of variants of unknown significances in genes.基因中意义未明变异的临床意义
J Gynecol Oncol. 2019 Jul;30(4):e80. doi: 10.3802/jgo.2019.30.e80. Epub 2019 May 9.
2
Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.采用新一代测序技术对家族性乳腺癌女性的 BRCA1 和 BRCA2 致病变体进行分析：一项病例对照研究。
BMC Cancer. 2019 Jul 22;19(1):722. doi: 10.1186/s12885-019-5950-4.
3
[Clinical significance and distribution of BRCA genes mutation in sporadic high grade serous ovarian cancer].[散发性高级别浆液性卵巢癌中BRCA基因突变的临床意义及分布]
Zhonghua Fu Chan Ke Za Zhi. 2017 Jan 25;52(1):26-31. doi: 10.3760/cma.j.issn.0529-567X.2017.01.007.
4
Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.突尼斯高危乳腺癌/卵巢癌家族中BRCA1和BRCA2大基因组重排的患病率：对基因检测的影响。
Cancer Genet. 2017 Jan;210:22-27. doi: 10.1016/j.cancergen.2016.11.002. Epub 2016 Nov 18.
5
The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.BRCA1 和 BRCA2 突变与前列腺癌风险、频率和死亡率的关联：一项荟萃分析。
Prostate. 2019 Jun;79(8):880-895. doi: 10.1002/pros.23795. Epub 2019 Mar 22.
6
BRCA-analyzer: Automatic workflow for processing NGS reads of BRCA1 and BRCA2 genes.BRCA-analyzer：BRCA1 和 BRCA2 基因 NGS 读取的自动处理工作流程。
Comput Biol Chem. 2018 Dec;77:297-306. doi: 10.1016/j.compbiolchem.2018.10.012. Epub 2018 Oct 23.
7
Changes in classification of genetic variants in BRCA1 and BRCA2.BRCA1和BRCA2基因变异分类的变化。
Arch Gynecol Obstet. 2018 Feb;297(2):279-280. doi: 10.1007/s00404-017-4631-2. Epub 2018 Jan 4.
8
Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.MMCI二十年的BRCA1和BRCA2分子分析——变异分类的当前进展
Klin Onkol. 2019 Summer;32(Supplementum2):51-71. doi: 10.14735/amko2019S51.
9
Next-Generation Sequencing of Tumors to Better Estimate the Clinical Significance of Non- BRCA Germline Deleterious Mutations.
J Clin Oncol. 2016 Dec;34(34):4183. doi: 10.1200/JCO.2016.67.7724. Epub 2016 Oct 31.
10
No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriers.巴基斯坦BRCA突变携带者后代中BRCA突变与性别比例之间无关联。
Breast Cancer Res Treat. 2008 Jan;107(1):155-6. doi: 10.1007/s10549-007-9521-z. Epub 2007 Feb 15.
引用本文的文献
1
The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer.肿瘤标志物在制定晚期卵巢癌治疗策略中的作用。
Int J Mol Sci. 2024 Oct 19;25(20):11239. doi: 10.3390/ijms252011239.
2
variants of uncertain significance in clinical practice: A case report.临床实践中意义未明的变异：一例病例报告。
Mol Clin Oncol. 2021 Nov;15(5):222. doi: 10.3892/mco.2021.2385. Epub 2021 Aug 31.
3
Prevalence and Spectrum of Germline and Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome.乳腺癌/卵巢癌中生殖系变异及意义未明变异的患病率和谱系：来自基因组的神秘信号
Front Oncol. 2021 Jun 11;11:682445. doi: 10.3389/fonc.2021.682445. eCollection 2021.
本文引用的文献
1
The influence of BRCA variants of unknown significance on cancer risk management decision-making.BRCA 意义未明变异对癌症风险管理决策的影响。
J Gynecol Oncol. 2019 Jul;30(4):e60. doi: 10.3802/jgo.2019.30.e60. Epub 2019 Feb 27.
2
Unclassified Variants of BRCA1 and BRCA2 in Korean Patients With Ovarian Cancer.韩国卵巢癌患者中 BRCA1 和 BRCA2 的未分类变异体。
Int J Gynecol Cancer. 2018 Feb;28(2):308-315. doi: 10.1097/IGC.0000000000001161.
3
The c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium.c.5096G>A p.Arg1699Gln（R1699Q）中等风险变异：ENIGMA 联盟的乳腺癌和卵巢癌风险评估及临床管理建议。
J Med Genet. 2018 Jan;55(1):15-20. doi: 10.1136/jmedgenet-2017-104560. Epub 2017 May 10.
4
Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea.基于韩国的临床证据，BRCA1基因c.5339T>C（p.L1780P）变异的分类从“意义未明”变更为“可能致病”。
Breast. 2017 Jun;33:109-116. doi: 10.1016/j.breast.2017.03.006. Epub 2017 Mar 30.
5
BRCA1/2 germline missense mutations: a systematic review.BRCA1/2 基因种系错义突变：一项系统评价
Eur J Cancer Prev. 2018 May;27(3):279-286. doi: 10.1097/CEJ.0000000000000337.
6
Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls.根据 ACMG 标准和指南，使用相关的种族对照，对韩国患者的 BRCA1 和 BRCA2 变异体进行重新分类后，鉴定出一种新的 BRCA1 致病性突变。
Cancer Res Treat. 2017 Oct;49(4):1012-1021. doi: 10.4143/crt.2016.433. Epub 2017 Jan 17.
7
Comparison of Clinical Outcomes of Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients.病理突变、意义未明变异或野生型上皮性卵巢癌患者的临床结局比较
Cancer Res Treat. 2017 Apr;49(2):408-415. doi: 10.4143/crt.2016.135. Epub 2016 Jul 27.
8
The Clinical Significance of Unknown Sequence Variants in BRCA Genes.BRCA 基因中未知序列变异的临床意义。
Cancers (Basel). 2010 Sep 10;2(3):1644-60. doi: 10.3390/cancers2031644.
9
Unclassified variants in BRCA genes: guidelines for interpretation.BRCA 基因中的未分类变异：解读指南。
Ann Oncol. 2011 Jan;22 Suppl 1:i18-23. doi: 10.1093/annonc/mdq661.
10
BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.韩国卵巢癌患者的BRCA1和BRCA2种系突变
J Cancer Res Clin Oncol. 2009 Nov;135(11):1593-9. doi: 10.1007/s00432-009-0607-3. Epub 2009 Jun 5.
Zotero 插件